July 12, 2024
Fertility Test Market

The Growing Infertility Issues And Low Birth Rates Are Driving The Fertility Test Market

Fertility tests aid in identifying fertility issues such as ovulation problems, low sperm count, fallopian tube damage and other infertility-related disorders. The tests determine the stages of ovulation and fertility window through urine and blood tests that detect the levels of luteinizing hormone, follicle-stimulating hormone and estradiol/progesterone. Home kits with ovulation prediction strips and digital hormone tests help women identify their fertility phases for planning conception. The rising cases of infertility owing to lifestyle changes, health conditions, sexually transmitted diseases and increasing age of first-time mothers are fueling the demand for fertility tests.

The global Fertility Test Market is estimated to be valued at US$ 579.1 Mn in 2023 and is expected to exhibit a CAGR of 4.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

One of the key trends in the fertility test market is the growth in direct-to-consumer testing. Several leading players are offering home use fertility testing kits that can be purchased online or from retail stores without a prescription. This has made fertility screening convenient and more affordable. For instance, Modern Fertility offers a fertility testing panel that tests AMH, FSH, estradiol, and Anti-Müllerian hormone levels through an at-home finger-prick blood test. Another trend is the advancement in fertility test technologies. Developers are focusing on innovations such as wearable biosensors, microfluidics, artificial intelligence and smartphone-enabled devices to introduce novel and easy-to-use fertility monitoring solutions. This is expected to boost the adoption of fertility tests.

Porter’s Analysis

Threat of new entrants: Low due to high capital requirements for R&D and marketing.

Bargaining power of buyers: Moderate as test kits are widely available and buyers have multiple options.

Bargaining power of suppliers: Low as raw materials are generic in nature.

Threat of new substitutes: Low as other options lack accuracy and convenience provided by modern fertility test kits.

Competitive rivalry: High due to presence of few major players differentiating through innovation.

Key Takeaways

The Global Fertility Test Market Demand is expected to witness high growth. The global Fertility Test Market is estimated to be valued at US$ 579.1 Mn in 2023 and is expected to exhibit a CAGR of 4.9% over the forecast period 2023 to 2030.

Regional analysis: North America is expected to dominate the global fertility test market due to high awareness and access to advanced treatments. Asia Pacific is anticipated to witness fastest growth due to increasing women workforce and rising medical tourism.

Key players operating in the fertility test market are AstraZeneca, Novartis AG, GSP plc, Merck & Co., Inc., Verona Pharma plc, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim International GmbH.Key players are focusing on new product launches and mergers & acquisitions to strengthen their foothold.

1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it